These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 4561329

  • 1. Metabolic clearance of insulin in man.
    Genuth SM.
    Diabetes; 1972 Oct; 21(10):1003-12. PubMed ID: 4561329
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P, Vague J.
    Journ Annu Diabetol Hotel Dieu; 1972 Oct; 13(0):55-65. PubMed ID: 4605752
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in serum immunoreactive insulin in diabetes during the glucose tolerance and tolbutamide tests and its clinical significance].
    Kuniyoshi N.
    Nihon Naibunpi Gakkai Zasshi; 1972 Aug 20; 48(5):333-42. PubMed ID: 4673031
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alloxan diabetes in the pig (Sus domesticus). Response to glucose, tolbutamide and insulin administration.
    Romsos DR, Leveille GA, Allee GL.
    Comp Biochem Physiol A Comp Physiol; 1971 Nov 01; 40(3):557-68. PubMed ID: 4400017
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
    Melani F, Lawecki J, Bartelt KM, Pfeiffer EF.
    Diabetologia; 1967 Oct 01; 3(5):422-6. PubMed ID: 5620801
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum insulin in obesity and diabetes mellitus.
    Boshell BR, Chandalia HB, Kreisberg RA, Roddam RF.
    Am J Clin Nutr; 1968 Dec 01; 21(12):1419-28. PubMed ID: 5724820
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
    Pfeiffer EF.
    Acta Diabetol Lat; 1969 Sep 01; 6 Suppl 1():477-502. PubMed ID: 4906024
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.